PolyPid PYPD Stock
PolyPid Price Chart
PolyPid PYPD Financial and Trading Overview
| PolyPid stock price | 5.33 USD |
| Previous Close | 5.16 USD |
| Open | 5.2 USD |
| Bid | 3.66 USD x 200 |
| Ask | 6.55 USD x 200 |
| Day's Range | 5.04 - 5.24 USD |
| 52 Week Range | 3.06 - 5.73 USD |
| Volume | 99.33K USD |
| Avg. Volume | 215.27K USD |
| Market Cap | 104.61M USD |
| Beta (5Y Monthly) | 1.418 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -1.31 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 11.75 USD |
PYPD Valuation Measures
| Enterprise Value | 99.82M USD |
| Trailing P/E | N/A |
| Forward P/E | -4.1955194 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | N/A |
| Price/Book (mrq) | 19.433964 |
| Enterprise Value/Revenue | N/A |
| Enterprise Value/EBITDA | -3.314 |
Trading Information
PolyPid Stock Price History
| Beta (5Y Monthly) | 1.418 |
| 52-Week Change | 48.70% |
| S&P500 52-Week Change | 15.30% |
| 52 Week High | 5.73 USD |
| 52 Week Low | 3.06 USD |
| 50-Day Moving Average | 4.87 USD |
| 200-Day Moving Average | 4.53 USD |
PYPD Share Statistics
| Avg. Volume (3 month) | 215.27K USD |
| Avg. Daily Volume (10-Days) | 102.02K USD |
| Shares Outstanding | 20.31M |
| Float | 12.16M |
| Short Ratio | 1.36 |
| % Held by Insiders | 17.78% |
| % Held by Institutions | 34.55% |
| Shares Short | 195K |
| Short % of Float | 1.28% |
| Short % of Shares Outstanding | 0.95% |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor | 1:30 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2025 |
| Most Recent Quarter (mrq) | June 30, 2026 |
| Next Fiscal Year End | December 31, 2026 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | 0% |
| Gross Margin | 0% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -74.62% |
| Return on Equity (ttm) | -243.59% |
Income Statement
| Revenue (ttm) | N/A |
| Revenue Per Share (ttm) | N/A |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | N/A |
| EBITDA | -30118000 USD |
| Net Income Avi to Common (ttm) | -31501000 USD |
| Diluted EPS (ttm) | -1.31 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 6.56M USD |
| Total Cash Per Share (mrq) | 0.32 USD |
| Total Debt (mrq) | 1.57M USD |
| Total Debt/Equity (mrq) | 29.18 USD |
| Current Ratio (mrq) | 1.346 |
| Book Value Per Share (mrq) | 0.265 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -29003000 USD |
| Levered Free Cash Flow (ttm) | -17364124 USD |
Profile of PolyPid
| Country | United States |
| State | N/A |
| City | Petah Tikva |
| Address | 18 Hasivim Street |
| ZIP | 4959376 |
| Phone | 972 7 4719 5700 |
| Website | https://www.polypid.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 69 |
PolyPid Ltd., a biopharmaceutical company, developing targeted, locally administered, and prolonged-release therapeutics using its proprietary polymer-lipid encapsulation matrix (PLEX) technology to address unmet medical needs. Its lead product candidate is D-PLEX100, which is in a pivotal Phase 3 confirmatory trial for prevention of surgical site infections (SSIs) in patients undergoing abdominal colorectal surgery with large incisions. The company is also developing OncoPLEX, which is in preclinical stage for the treatment of intra-tumoral cancer. The company has a research and development collaboration with ImmunoGenesis, Inc. for the development of formulations to treat solid tumors. PolyPid Ltd. was incorporated in 2008 and is headquartered in Petah Tikva, Israel.
Q&A For PolyPid Stock
What is a current PYPD stock price?
PolyPid PYPD stock price today per share is 5.33 USD.
How to purchase PolyPid stock?
You can buy PYPD shares on the Tech Market Small exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for PolyPid?
The stock symbol or ticker of PolyPid is PYPD.
Which industry does the PolyPid company belong to?
The PolyPid industry is Biotechnology.
How many shares does PolyPid have in circulation?
The max supply of PolyPid shares is 20.31M.
What is PolyPid Price to Earnings Ratio (PE Ratio)?
PolyPid PE Ratio is now.
What was PolyPid earnings per share over the trailing 12 months (TTM)?
PolyPid EPS is -1.31 USD over the trailing 12 months.
Which sector does the PolyPid company belong to?
The PolyPid sector is Healthcare.
PolyPid PYPD included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
|
|
{{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
US Tech Composite
IXIC
US
|
26186.41 USD — |
-0.56
|
6.24B USD — | 25992.55 USD — | 26329.98 USD — | — - | 6.24B USD — |
|
US Tech Global Market Composite
NQGM
US
|
2212.82 USD — |
-0.16
|
— — | 2197.04 USD — | 2231.45 USD — | — - | — — |
|
US Tech Health Care
IXHC
US
|
1308.52 USD — |
+1.15
|
— — | 1296.22 USD — | 1310.89 USD — | — - | — — |
- {{ link.label }} {{link}}
